Moore Capital Management »

Taysha Gene Therapies shares owned by Moore Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 329k 4.47

More positions owned by Moore Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ally Financial (ALLY)
Bank of America Corporation (BAC)
Ubs Group SHS (UBS)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Apollo Global Mgmt (APO)
Coinbase Global Note 0.500% 6/0 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Etsy Note 0.125%10/0 (Principal)
Global Payments (GPN)
Fidelity National Information Services (FIS)

View all positions for Moore Capital Management

Top funds holding Taysha Gene Therapies

RA Capital Management
Goldman Sachs Group
venBio Select Advisor
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Group
State Street Corporation
Vanguard Capital Management
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays

View all funds holding Taysha Gene Therapies